-
Nasdaq-listed FSD Pharma To Advance Psychedelics Pipeline With $9 Million Acquisition Of Lucid Psycheceuticals
Wednesday, August 25, 2021 - 5:10pm | 363FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE), a life sciences holding company looking at cannabinoid and psychedelic-based medicines, announced it is entering a definitive agreement to acquire Lucid Psycheceuticals Inc. Lucid is a psychedelic pharmaceutical company focused on developing...